CAD review course
slated February
With its theme Emerging Concepts, Shifting
Practices, the Philippine Heart Center will be holding a
symposium as part of its 2007 Coronary Artery Disease (CAD)
Review Course on February 23-24.
Heart specialist and medical symposium head, Dr. Gilbert C.
Vilela, said the event will be unlike typical hospital review courses, which
focus mainly on previous patient cases, istead, this one will aim to identify
what works best for patients by reviewing treatment options and clinical
results.
Vilela observed that many physicians are not updated in the
management of cardiovascular (like hypertension) and metabolic (like diabetes)
diseases – conditions that have not been adequately addressed despite the
availability of new therapeutic options.
Coronary artery disease occurs when the arteries that supply
blood to the heart muscle (the coronary arteries) harden and narrow, reducing or
obstructing much-needed blood flow and oxygen to the heart. This results in
angina, heart attack, heart failure, or arrhythmias. CAD is the most common type
of heart disease. In the U.S. it is the leading cause of death among men and
women. "Much of medicine is based on choosing the best treatment, and we need to
ensure that the choice is supported by good scientific evidence," says Vilela.
The idea behind the 2007 CAD review course is to bridge the
gap between science and the clinics – to push for the application of the "new
emerging science" into the medical practice, so that Filipino patients would
have better treatment outcomes, Vilela says.
Schwarz Pharma Philippines, a subsidiary of Schwarz Pharma AG in Monheim,
Germany is supporting the event. For details, call Dr. Kathleen Go at 0917
5490050.